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Dear Editors,
The global coronavirus pandemic has clearly demonstrated
the great urgency to collect and use patient data effectively to
understand, track and manage the spread of Covid-19. The
value of patient data in this pandemic is undeniable, however
considerations around how – and by whom - such data should
be collected, accessed and used, and for what purposes, remain
to be fully debated and resolved. Who decides, and how such
decisions are made, remain unclear. We argue that, as with
all uses of patient data, public engagement and deliberation
are essential for good governance and are key to establish and
maintain a legitimate social licence for data practices around
Covid-19.
Previous data controversies have clearly demonstrated the
importance of establishing a social licence for data practices,
and that there can be meaningful differences between what is
legally permissible and what is socially acceptable [1]. The
standard response to such controversies has typically been
reemphasising commitments to public engagement [2] in order
to (re)build or restore public trust [3]. This overlooks the dy-
namic nature of public trust, and the importance of ongoing
relationships to establish and maintain trust over time.
Commitments to public engagement must go beyond lip
service [2] and also need to recognise that not only are there
different approaches to public engagement, some are more le-
gitimate and useful than others. We advocate engaging the
public, policy makers and users of patient data in collective de-
liberation to enable mutual learning and informed policy mak-
ing. This would make the social licence epistemically superior
and more legitimate.
We already have a consensus statement on public involve-
ment and engagement (PI&E) relating to data-intensive health
research published in IJPDS last year [2]. This statement
was co-authored by 31 international researchers, practitioners
and patient representatives from the U.K., Ireland, Australia,
Canada, Finland and the Netherlands. It sets out eight prin-
ciples to underpin best practice in this field and to inform the
design, implementation and evaluation of PI&E strategies and
activities.
The principles put forward in the consensus statement are,
that public involvement and engagement with data-intensive
health research should:
1. Have institutional buy-in;
2. Have clarity of purpose;
3. Be transparent;
4. Involve two-way communication;
5. Be inclusive and accessible to broad publics;
6. Be ongoing;
7. Be designed to produce impact;
8. Be evaluated.
It is time to reinvigorate these principles so that public en-
gagement is not overlooked in the rapid response to COVID-
19.
The key premise of the consensus statement is that the
public should not be characterised as a problem to be over-
come, but a key part of the solution towards establishing so-
cially beneficial data-intensive health research for all. This
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resonates in the current context where it is important to avoid
caricaturing “the public” or speculating on how “the public” will
respond to particular measures or data practices, but rather to
engage diverse publics in consequential deliberation to inform
and shape policy responses and data practices.
A number of public engagement initiatives relating to
Covid-19 have been announced [4] and innovative approaches
are being developed to engage the public in these discussions
during lockdown and beyond. Innovation in using digital meth-
ods is clearly vital if we are to engage diverse publics at this
time in the development and governance of new data initia-
tives. We must also strive to be inclusive of those who are not
already online or have little experience of digital communica-
tion.
Despite the speed required to deal with the pandemic, it
is vital to adhere to these principles not just to do things well
in relation to the current crisis, but because current practices,
hastily developed, will forge the way for future ways of work-
ing. The pandemic brings with it an imperative to realise the
value of PI&E in shaping socially acceptable and ethically ro-
bust data practices and to raise the profile of PI&E increasing
public interest in these activities. This will ensure that the
social licence generated will endure because it is based on au-
thoritative and authentic deliberation.
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